Pharmaceutical News

RSS

GPs’ advice on secondary prevention medications disregarded by some stroke survivors, study finds

Some stroke survivors say they are disregarding general practitioners' advice on secondary prevention medications, such as statins, with some patients stopping their medication completely, according to a study of an online stroke forum led by Queen Mary University of London.

10 Apr 2017

BMJ Innovations releases first collaborative definition of patient centricity co-created by AstraZeneca

AstraZeneca today announced that BMJ Innovations has published the first collaborative definition of patient centricity for the pharmaceutical industry.

10 Apr 2017

New drug can reduce tardive dyskinesia in patients with schizophrenia, mood disorder

Antipsychotic treatment can cause involuntary movements such as lip smacking, tongue protrusions and excessive eye blinking. These movements typically occur after more than 3 months of treatment and are called tardive dyskinesia.

7 Apr 2017

JAPhA articles highlight role of pharmacists in controlling opioid crisis

Pharmacists often face serious challenges when trying to balance the needs of patients with chronic pain and preventing prescription drug misuse, abuse, and overdose.

7 Apr 2017

Scientists discover protein that helps provide better vaccination response

Researchers have discovered a protein they believe would help make vaccinations more effective and provide protection from other diseases such as cancer.

7 Apr 2017

FDA grants approval for two drugs to treat hepatitis C virus in children

The U.S. Food and Drug Administration today approved supplemental applications for Sovaldi (sofosbuvir) and Harvoni (ledipasvir and sofosbuvir) to treat hepatitis C virus (HCV) in children ages 12 to 17. Harvoni and Sovaldi were previously approved to treat HCV in adults.

7 Apr 2017

Patients with inducible urticaria can benefit from treatment with asthma drug

Patients who develop itchy wheals in response to cold or friction benefit from treatment with omalizumab, a drug normally used to treat asthma.

7 Apr 2017

Galenica Group focuses on pharmaceuticals as it becomes Vifor Pharma Group

The Galenica Group announced today that it successfully completed the initial public offering (IPO) of Galenica Santé, its leading provider of health, beauty and well-being products and services on the Swiss Stock Exchange (SIX). Following the IPO, Galenica Group becomes Vifor Pharma Group and will be listed on the Swiss Stock Exchange under its new ticker, VIFN. The company has thus taken the final steps toward separating into two independent companies: Vifor Pharma Group and Galenica Santé.

From CSL Ltd 7 Apr 2017

Biomedical engineers develop new method for delivering drugs to specific neurons

Biomedical engineers have developed a way to deliver drugs to specific types of neurons in the brain, providing an unprecedented ability to study neurological diseases while also promising a more targeted way to treat them.

6 Apr 2017

Use of antimuscarinics linked to depressive disorder in women with overactive bladder

A recent study found that women with overactive bladder who received antimuscarinics were 38% more likely to be diagnosed with depressive disorder within the next 3 years than those who did not receive antimuscarinics.

6 Apr 2017

Antibody treatment protects non-human primates against deadly Marburg and Ravn viruses

An antibody treatment successfully protected nonhuman primates against the deadly Marburg and Ravn viruses even when given five days after becoming infected, according to the latest findings of a collaborative team from The University of Texas Medical Branch at Galveston, Mapp Biopharmaceutical Inc., and Vanderbilt University. The findings are now available in Science Translational Medicine.

6 Apr 2017

Study highlights need for weight-appropriate dosing of healthy fat supplements

Body weight plays a significant role in how much benefit children may get from consuming "good" fats, new research suggests.

5 Apr 2017

X-ray study sheds new light on promising drug target

Researchers hope to design a new generation of drugs against an array of deadly diseases. The task, however, is costly, arduous and often ineffective. One of the key challenges is understanding a particular class of proteins adorning cell surfaces, which are the targets of the majority of pharmaceutical drugs.

5 Apr 2017

Newly-discovered mechanism for compound may help prevent neurologic damage

Researchers at Oregon State University have found that a compound called rapamycin has unusual properties that may help address neurologic damage such as Alzheimer's disease.

5 Apr 2017

Insilico Medicine announces launch of intelligently-formulated nutraceuticals in Europe

Insilico Medicine, Inc, a big data analytics company applying latest advances in deep learning to drug discovery, biomarker development, and aging research today announced that the line of nutraceuticals developed in collaboration with Life Extension will be available across Europe.

5 Apr 2017

Hebrew University announces launch of new Center for conducting research on cannabinoids

The Hebrew University of Jerusalem has announced the launch of a Multidisciplinary Center on Cannabinoid Research.

5 Apr 2017

Oxytocin system may be key target for developing medications to treat opioid addiction

A new review of published research indicates that the oxytocin system—a key player in social reward and stress regulation—is profoundly affected by opioid use.

5 Apr 2017

Sodium citrate nasal spray could offer temporary improvement in ability to smell

A substance commonly used to treat bladder issues could temporarily treat people who have lost their sense of smell, according to research published in the journal Clinical Otolaryngology.

5 Apr 2017

Dose sparing could increase vaccine availability without compromising safety

The currently licensed seasonal trivalent influenza vaccines contain 15 micrograms of viral hemagglutinin protein per strain for adults, and up to 60 micrograms for elderly individuals; however, due to recent shortages, reducing these doses would be highly desirable.

5 Apr 2017

Six important things to know about opioid crisis

While opioid drugs play an important role in pain management, an alarming increase in opioid diversion, opioid use disorder, and opioid-related mortality and morbidity in recent years has created a healthcare crisis in the United States.

5 Apr 2017

Pharmaceutical News

GPs’ advice on secondary prevention medications disregarded by some stroke survivors, study finds

BMJ Innovations releases first collaborative definition of patient centricity co-created by AstraZeneca

New drug can reduce tardive dyskinesia in patients with schizophrenia, mood disorder

JAPhA articles highlight role of pharmacists in controlling opioid crisis

Scientists discover protein that helps provide better vaccination response

FDA grants approval for two drugs to treat hepatitis C virus in children

Patients with inducible urticaria can benefit from treatment with asthma drug

Galenica Group focuses on pharmaceuticals as it becomes Vifor Pharma Group

Biomedical engineers develop new method for delivering drugs to specific neurons

Use of antimuscarinics linked to depressive disorder in women with overactive bladder

Antibody treatment protects non-human primates against deadly Marburg and Ravn viruses

Study highlights need for weight-appropriate dosing of healthy fat supplements

X-ray study sheds new light on promising drug target

Newly-discovered mechanism for compound may help prevent neurologic damage

Insilico Medicine announces launch of intelligently-formulated nutraceuticals in Europe

Hebrew University announces launch of new Center for conducting research on cannabinoids

Oxytocin system may be key target for developing medications to treat opioid addiction

Sodium citrate nasal spray could offer temporary improvement in ability to smell

Dose sparing could increase vaccine availability without compromising safety

Six important things to know about opioid crisis

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Latest News